Progress and Discussion of Perioperative Targeted Therapy in Patients with EGFR-mutated Resectable Non-small Cell Lung Cancer
Autor: | Peng SONG, Yong CUI |
---|---|
Jazyk: | čínština |
Rok vydání: | 2024 |
Předmět: | |
Zdroj: | Chinese Journal of Lung Cancer, Vol 27, Iss 5, Pp 383-390 (2024) |
Druh dokumentu: | article |
ISSN: | 1009-3419 1999-6187 |
DOI: | 10.3779/j.issn.1009-3419.2024.106.11 |
Popis: | Lung cancer is still the leading cause of cancer death worldwide. Non-small cell lung cancer (NSCLC) is the main pathological type of lung cancer, accounting for about 80%. Approximately 30% of all patients with NSCLC have resectable early and middle stage disease at the time of diagnosis. Recently, the epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have made a major breakthrough in the adjuvant targeted therapy of EGFR-mutated resectable NSCLC, and are recommended by the guidelines for clinical use. In this review, we summarize the clinical research progress of perioperative adjuvant targeted therapy for EGFR-mutated resectable NSCLC, and discuss the key issues in the clinical researches. |
Databáze: | Directory of Open Access Journals |
Externí odkaz: |